Literature DB >> 20512944

The role of surgery in the treatment of gastric cancer.

Yingqiang Shi1, Ye Zhou.   

Abstract

During the past decades, despite considerable improvements in the management of gastric cancer, surgery remains the main curative treatment. However, there is still debate about the extent of gastrectomy and lymphadenectomy, multivisceral resection, the requirement for reoperation for specimens with positive margins, the selection of neoadjuvant treatment and the management strategy of early gastric cancer. This review is to evaluate the above issues based on the reported prospective and retrospective studies. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20512944     DOI: 10.1002/jso.21455

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  28 in total

Review 1.  The role of miR-148a in gastric cancer.

Authors:  Jiazeng Xia; Xiaoqiang Guo; Jiang Yan; Kaiyuan Deng
Journal:  J Cancer Res Clin Oncol       Date:  2014-09       Impact factor: 4.553

2.  MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.

Authors:  Benjamin Balluff; Sandra Rauser; Stephan Meding; Mareike Elsner; Cedrik Schöne; Annette Feuchtinger; Christoph Schuhmacher; Alexander Novotny; Uta Jütting; Giuseppina Maccarrone; Hakan Sarioglu; Marius Ueffing; Herbert Braselmann; Horst Zitzelsberger; Roland M Schmid; Heinz Höfler; Matthias P Ebert; Axel Walch
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

3.  Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

Authors:  Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer.

Authors:  Lichao Sun; Chunguang Guo; Hebao Yuan; Joseph Burnett; Jian Pan; Zhihua Yang; Yuliang Ran; Ila Myers; Duxin Sun
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

5.  MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.

Authors:  Sumitaka Yamanaka; Alexandru V Olaru; Fangmei An; Delgermaa Luvsanjav; Zhe Jin; Rachana Agarwal; Ciprian Tomuleasa; Irinel Popescu; Sorin Alexandrescu; Simona Dima; Mihaela Chivu-Economescu; Elizabeth A Montgomery; Michael Torbenson; Stephen J Meltzer; Florin M Selaru
Journal:  Dig Liver Dis       Date:  2012-03-28       Impact factor: 4.088

6.  miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP.

Authors:  Tiefeng Qiu; Keping Wang; Xianwen Li; Jianhua Jin
Journal:  Exp Ther Med       Date:  2018-10-01       Impact factor: 2.447

7.  Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.

Authors:  Na Wang; Junjun She; Wei Liu; Jing Shi; Qi Yang; Bingyin Shi; Peng Hou
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.

Authors:  Lijie Gong; Yingjie Xia; Zhenyuan Qian; Ji Shi; Jungang Luo; Guangyuan Song; Ji Xu; Zaiyuan Ye
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

Review 9.  Gastric cancer: Current status of lymph node dissection.

Authors:  Maurizio Degiuli; Giovanni De Manzoni; Alberto Di Leo; Domenico D'Ugo; Erica Galasso; Daniele Marrelli; Roberto Petrioli; Karol Polom; Franco Roviello; Francesco Santullo; Mario Morino
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

10.  MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.

Authors:  Shuai Chang; Shicai He; Guanglin Qiu; Jing Lu; Jin Wang; Junsong Liu; Lin Fan; Wei Zhao; Xiangming Che
Journal:  Tumour Biol       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.